Dong-A Socio Holdings completes merger of wholly owned unit Dong-A Pharmaceutics

• Dong-A Socio Holdings completed a merger of its wholly owned unit Dong-A Pharmaceutical into the surviving company, also renamed Dong-A Pharmaceutical.
• The deal used a 1:0 merger ratio with no new shares issued and no cash consideration paid.
• Merger effective date was Oct. 1, 2026; registration was scheduled for Oct. 2, 2026.
• Objection notices were filed by 103 shareholders covering 6,166 shares, equal to 0.09% of shares outstanding.
• Combined pro forma totals as of June 30, 2026: assets 1,411,503 million won; liabilities 463,517 million won; equity 947,986 million won.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dong-A Socio Holdings Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261002000364), on October 02, 2026, and is solely responsible for the information contained therein.